Because of its specificity, AOD-9604 is a promising medication for the treatment of obesity and research on metabolic diseases associated with obesity (3)
10.1007/s00011-016-0943-0 152 ZhouZ.LuJ.LiuW
Sometimes, though, research zooms in on just one area
BPC-157/TB-500/GHK-Cu 10+10+50mg (GLOW blend 70mg) $200.00 Volume discounts Auto-applied at checkout Free shipping on orders of $200+ Compound Identity COMPOUND NAME BPC+TB500+GHK-Cu SYNONYMS GLOW blend CAS NUMBER 137525-51-0 (BPC-157), 77591-33-4 (TB500), 300801-03-0 (GHK-Cu) MOLECULAR FORMULA C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu) MOLECULAR WEIGHT ~6786.95 g/mol STRUCTURE Multi-peptide blend PEPTIDE SEQUENCE Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (BPC-157), Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (TB500), Gly-His-Lys (GHK-Cu) CHEMICAL STRUCTURE Molecular Formula : C 62 H 98 N 16 O 22 (BPC-157), C 212 H 350 N 56 O 78 S (TB500), C 28 H 46 CuN 12 O 8 (GHK-Cu) Source: PubChem Mechanism of Action GLOW blend works through multiple complementary biological pathways that promote tissue repair, regeneration, and inflammation control
Clinical response and haematological parameters are better indicators of treatment efficacy
Each vial is supplied as a stable lyophilised powder and COA-verified to ensure purity, consistency, and reliability for controlled laboratory studies
